I Am Not Optimistic

There are differences of opinion over the precise definition of scientific misconduct and over how to deal with it. We also don’t have a very good idea on how often it occurs. It probably is not unreasonable to assume, however, that it happens much more frequently than the few highly publicized cases would suggest—if only because it is unlikely that all instances of misconduct are discovered and, of those discovered, that all become public knowledge. Moreover, my own experience s

Written byJerome Jacobstein
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

There are differences of opinion over the precise definition of scientific misconduct and over how to deal with it. We also don’t have a very good idea on how often it occurs. It probably is not unreasonable to assume, however, that it happens much more frequently than the few highly publicized cases would suggest—if only because it is unlikely that all instances of misconduct are discovered and, of those discovered, that all become public knowledge.

Moreover, my own experience suggests that it is nearly impossible to get a fair investigation of the facts unless there is incon trovertible proof from the outset. The experience of others suggests that even that may not be enough, especially if the accuser is a junior scientist.

What is so remarkable (and disturbing) about my case is that in spite of having virtually everything in my favor, I very nearly lost. I was of relatively ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies